Yves Durocher
13Patents
2h-index
19Co-inventors
51Inventor score
Filing activity: Mar 19, 1999 → Sep 20, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8551774B2 | Expression vectors containing a truncated epstein barr nuclear antigen 1 lacking the Gly-Gly-Ala domain for enhanced transient gene expression | Chemistry; Metallurgy | 7 | Active |
| US8637315B2 | Process, vectors and engineered cell lines for enhanced large-scale transfection | Chemistry; Metallurgy | 2 | Active |
| US10738115B2 | Humanized antibodies transmigrating the blood-brain barrier and uses thereof | Chemistry; Metallurgy | 1 | Active |
| US11945858B2 | Antibodies and antibody fragments against HNAV1.7 channel and their use in pain and cancer indications | Chemistry; Metallurgy | 0 | Active |
| US10858629B2 | Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells | Chemistry; Metallurgy | 0 | Active |
| US9353382B2 | Process, vectors and engineered cell lines for enhanced large-scale transfection | Chemistry; Metallurgy | 0 | Active |
| US11591408B2 | Antibody glycoconjugates and methods of production and use | Chemistry; Metallurgy | 0 | Active |
| US6596508B2 | CRE-inducible expression system | Chemistry; Metallurgy | 0 | Expired |
| US9085627B2 | Expression system with SAR element from IFNα2 | Chemistry; Metallurgy | 0 | Active |
| US10421950B2 | Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells | Chemistry; Metallurgy | 0 | Active |
| US11702466B2 | Fusion protein comprising a blood-brain barrier (BBB)-crossing single domain antibody Fc5, an immunoglobulin Fc fragment and a beta-amyloid binding polypeptide (ABP) | Chemistry; Metallurgy | 0 | Active |
| US10487153B2 | Carbonic anhydrase IX-specific antibodies and uses thereof | Physics | 0 | Active |
| US12240916B2 | Intrabodies for reducing FUT8 activity | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.